Cline Scientific
0.074 SEK +19.03%1 investor is following this company
Cline Scientific develops cancer diagnostics and regenerative medicine treatments. The company is working with R&D through joint collaborations with pharmaceutical companies and academic researchers around the world. The patented surface nanotechnology is used in cell-based products and processes to drive projects within Life Science into and through the clinical phase. Cline operates out of Gothenburg, Sweden and was founded in 2012 from a long term research project in surface nanotechnology.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CLINE B
Daily low / high price
0.074 / 0.075
SEK
Market cap
3.32M SEK
Turnover
6.88K SEK
Volume
93K
Financial calendar
Interim report
23.08.2024
Annual report
21.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Patrik Sundh | 15.3 % | 40.6 % |
Avanza Pension | 8.0 % | 5.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Annual Report for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Notice to the Annual General Meeting of Cline Scientific AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools